Caris Life Sciences, Inc. (CAI)
28.30
-0.05
(-0.18%)
USD |
NASDAQ |
Oct 02, 16:00
28.44
+0.14
(+0.49%)
After-Hours: 20:00
Caris Life Sciences Gross Profit Margin (Quarterly) : 68.10% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 68.10% |
| March 31, 2026 | 65.39% |
| December 31, 2025 | 75.43% |
| September 30, 2025 | 68.03% |
| June 30, 2025 | 62.67% |
| Date | Value |
|---|---|
| March 31, 2025 | 47.19% |
| December 31, 2024 | 54.42% |
| September 30, 2024 | 43.70% |
| June 30, 2024 | 37.54% |
| March 31, 2024 | 32.37% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| CareDx, Inc. | 73.37% |
| Natera, Inc. | 63.70% |
| Myriad Genetics, Inc. | 62.51% |
| BioRestorative Therapies, Inc. | -157.8% |
| Exagen, Inc. | 61.27% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.51% |
| Return on Assets | 9.63% |
| Return on Invested Capital | 10.84% |
| Profit Margin (Quarterly) | -0.24% |
| Operating Margin (Quarterly) | 10.21% |
| Return on Net Operating Assets | 39.01% |